Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;18(4):433-456.
doi: 10.2174/1872210517666230822100324.

Nano - Based Therapeutic Strategies in Management of Rheumatoid Arthritis

Gunjan Nautiyal  1 , Shiv Kant Sharma  1 , Dhirender Kaushik  1 , Parijat Pandey  1
Affiliations
Review

Nano - Based Therapeutic Strategies in Management of Rheumatoid Arthritis

Gunjan Nautiyal et al. Recent Pat Nanotechnol. 2024.

Abstract

Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease, progressively distinctive via cartilage destruction, auto-antibody production, severe joint pain, and synovial inflammation. Nanotechnology represents as one of the utmost promising scientific technologies of the 21st century. It exhibits remarkable potential in the field of medicine, including imaging techniques and diagnostic tools, drug delivery systems and providing advances in treatment of several diseases with nanosized structures (less than 100 nm).

Objective: Conventional drugs as a cornerstone of RA management including disease-modifying antirheumatic drugs (DMARDS), Glucocorticosteroids, etc are under clinical practice. Nevertheless, their low solubility profile, poor pharmacokinetics behaviour, and non-targeted distribution not only hamper their effectiveness, but also give rise to severe adverse effects which leads to the need for the emergence of nanoscale drug delivery systems.

Methods: Several types of nano-diagnostic agents and nanocarriers have been identified; including polymeric nanoparticles (NPs), liposomes, nanogels, metallic NPs, nanofibres, carbon nanotubes, nano fullerene etc. Various patents and clinical trial data have been reported in relevance to RA treatment.

Results: Nanocarriers, unlike standard medications, encapsulate molecules with high drug loading efficacy and avoid drug leakage and burst release before reaching the inflamed sites. Because of its enhanced targeting specificity with the ability to solubilise hydrophobic drugs, it acts as an enhanced drug delivery system.

Conclusion: This study explores nanoparticles potential role in RA as a carrier for site-specific delivery and its promising strategies to overcome the drawbacks. Hence, it concludes that nanomedicine is advantageous compared with conventional therapy to enhanced futuristic approach.

Keywords: Rheumatoid arthritis; autoimmune; nanodiagnostic agents; nanotechnology; patents.; target specificity.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Bandigari P.; Dongamanti A.; Evaluation of anti-inflammatory and anti-arthritic activities of semecarpus anacardium in experimental animals. J Pharm Negat Results 2023,1179-1187
    1. Nocton J.; Co D.; Arthritis. Nelson Pediatric Symptom-Based Diagnosis 2018,594-613 - DOI
    1. Brennan-Olsen S.L.; Cook S.; Leech M.T.; Prevalence of arthritis according to age, sex and socioeconomic status in six low and middle income countries: Analysis of data from the World Health Organization study on global AGEing and adult health (SAGE) Wave 1. BMC Musculoskelet Disord 2017,18(1),271 - DOI - PubMed
    1. Ma L.; Cranney A.; Holroyd-Leduc J.M.; Acute monoarthritis: What is the cause of my patient’s painful swollen joint? CMAJ 2009,180(1),59-65 - DOI - PubMed
    1. Hazes J.M.W.; Luime J.J.; The epidemiology of early inflammatory arthritis. Nat Rev Rheumatol 2011,7(7),381-390 - DOI - PubMed